Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.57% | -10.45% | 4.11% | 1.88% | 64.06% |
| Total Depreciation and Amortization | -31.89% | -33.18% | 0.56% | 2.88% | 103.11% |
| Total Amortization of Deferred Charges | 33.59% | 34.85% | -31.68% | -30.12% | -- |
| Total Other Non-Cash Items | 511.03% | 503.52% | 1,860.36% | 1,916.22% | -102.36% |
| Change in Net Operating Assets | 73.69% | 74.17% | -- | -- | -1,116.93% |
| Cash from Operations | 32.18% | 33.45% | 14.21% | 12.21% | -62.13% |
| Capital Expenditure | -1,073.21% | -1,048.21% | 52.06% | 50.87% | 90.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -492.31% | -476.92% | 61.73% | 60.83% | -333.33% |
| Cash from Investing | -962.32% | -940.58% | 55.60% | 54.57% | 88.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -41.85% | -41.85% | -5.39% | -5.39% | 49.59% |
| Issuance of Common Stock | -16.97% | -16.97% | -- | -- | -0.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -20.74% | -22.22% | -5.42% | -7.77% | 0.61% |
| Foreign Exchange rate Adjustments | -14,242.86% | -13,942.86% | -- | -- | -97.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.17% | -24.61% | 19.02% | 17.14% | -27.02% |